This inventor holds 1 USPTO granted patent. Top assignee: Pharma Mar, S.a.. Active years: 2010.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2010
Title: Carmen Schleissner Sánchez: Innovator in Genetic Engineering
Introduction
Carmen Schleissner Sánchez is a notable inventor based in Madrid, Spain. He has made significant contributions to the field of genetic engineering, particularly in the biosynthesis of safracin molecules. His innovative work has implications for various applications in biotechnology.
Latest Patents
Carmen holds a patent titled "Gene cluster involved in safracin biosynthesis and its uses for genetic engineering." This patent discloses a gene cluster that includes open reading frames encoding polypeptides sufficient to direct the synthesis of a safracin molecule. The patent also covers a nucleic acid sequence that comprises at least SEQ ID NO:1, along with variants or portions of several specific genes involved in this biosynthetic pathway.
Career Highlights
Carmen is currently employed at Pharma Mar, S.A., a company known for its focus on biotechnology and pharmaceuticals. His work at Pharma Mar has allowed him to explore and develop innovative solutions in the field of genetic engineering.
Collaborations
Carmen collaborates with talented professionals in his field, including Ana Velasco Iglesias and Fernando De La Calle. These collaborations enhance the research and development efforts at Pharma Mar, contributing to advancements in biotechnology.
Conclusion
Carmen Schleissner Sánchez is a pioneering inventor whose work in genetic engineering is paving the way for future innovations. His contributions, particularly in safracin biosynthesis, highlight the importance of research and collaboration in advancing biotechnology.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
